U.S. Medical Foods Market To Surpass US$ 38,764.7 Mn By 2027
The U.S. medical foods market is expected to exhibit a CAGR of 17.1% over the forecast period, owing to increasing awareness about medical foods in the U.S. and rising risks of gastrointestinal disease such as Cohn’s diseases or ulcerative colitis in the U.S. For instance, according to the Crohn's & Colitis Foundation of America 2017 report, around 1.4 million people were affected from inflammatory bowel disease, of which 600,000 had Crohn’s disease or ulcerative colitis in the U.S. Get More Insights (at) https://www.coherentmarketinsights.com/market-insight/us-medical-foods-market-3215
The U.S. medical foods market is expected to exhibit a CAGR of 17.1% over the forecast period, owing to increasing awareness about medical foods in the U.S. and rising risks of gastrointestinal disease such as Cohn’s diseases or ulcerative colitis in the U.S. For instance, according to the Crohn's & Colitis Foundation of America 2017 report, around 1.4 million people were affected from inflammatory bowel disease, of which 600,000 had Crohn’s disease or ulcerative colitis in the U.S.
Get More Insights (at) https://www.coherentmarketinsights.com/market-insight/us-medical-foods-market-3215
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
UNITED STATE<br />
MEDICAL FOODS<br />
MARKET<br />
<strong>Market</strong> Size (2019)<br />
<strong>US$</strong> 10,991.5 <strong>Mn</strong><br />
CAGR (2019-<strong>2027</strong>)<br />
17.1 %<br />
MAJOR DRIVERS<br />
Increasing incidence of gastrointestinal, infectious, and other diseases<br />
Increasing awareness regarding prebiotics and probiotic products<br />
Novel product approval/launch<br />
SEGMENTATION (SCOPE)<br />
<strong>By</strong> Food Type<br />
Prebiotics<br />
Probiotics<br />
Probiotic <strong>Foods</strong><br />
Probiotic Supplements<br />
Food Supplements<br />
<strong>By</strong> Disease Indication<br />
Inflammatory Bowel Disease<br />
Ulcerative Colitis<br />
Crohn’s Disease<br />
Irritable Bowel Syndrome<br />
Others<br />
<strong>By</strong> Distribution Channel<br />
Hospitals<br />
Retail Channel<br />
Online Channel<br />
MAJOR PLAYERS<br />
Enterome SA<br />
Yakult Honsha Co., Ltd.<br />
Abbott<br />
ExeGi Pharma, LLC.<br />
VSL Pharmaceuticals, Inc.<br />
Entera Health, Inc.<br />
Meiji Holdings Co., Ltd.<br />
Danone<br />
Nestlé S.A.<br />
Coherent <strong>Market</strong> Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by<br />
helping them make Critical business decisions. We are headquartered in India, having office al global financial capital in the U.S. Our client base includes players from<br />
across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results<br />
through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and<br />
syndicated market research reports that help our clients create visionary growth plans to provide traction to their business.
Change language